Prognosis in HR-positive metastatic breast cancer with HER2-low versus HER2-zero treated with CDK4/6 inhibitor and endocrine therapy: a meta-analysis
Article in Frontiers in Oncology (August 2024)
The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.
Article in Frontiers in Oncology (August 2024)
Article in Cancers (August 2024)
Article in Clinical Breast Cancer (May 2024)